407 related articles for article (PubMed ID: 7964611)
1. The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers.
Treichel U; Meyer zum Büschenfelde KH; Stockert RJ; Poralla T; Gerken G
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3021-9. PubMed ID: 7964611
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated entry of hepatitis B virus particles into liver cells.
Treichel U; Meyer zum Büschenfelde KH; Dienes HP; Gerken G
Arch Virol; 1997; 142(3):493-8. PubMed ID: 9349295
[TBL] [Abstract][Full Text] [Related]
3. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences.
Mabit H; Dubanchet S; Capel F; Dauguet C; Petit MA
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2681-9. PubMed ID: 7931154
[TBL] [Abstract][Full Text] [Related]
4. Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface.
Yang J; Wang F; Tian L; Su J; Zhu X; Lin L; Ding X; Wang X; Wang S
Arch Virol; 2010 Jun; 155(6):881-8. PubMed ID: 20364278
[TBL] [Abstract][Full Text] [Related]
5. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47).
Petit MA; Dubanchet S; Capel F; Voet P; Dauguet C; Hauser P
Virology; 1991 Feb; 180(2):483-91. PubMed ID: 1703368
[TBL] [Abstract][Full Text] [Related]
6. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
7. Complement-mediated cytotoxicity and inhibition of ligand binding to hepatocytes by woodchuck hepatitis virus-induced autoantibodies to asialoglycoprotein receptor.
Diao J; Churchill ND; Michalak TI
Hepatology; 1998 Jun; 27(6):1623-31. PubMed ID: 9620336
[TBL] [Abstract][Full Text] [Related]
8. The clinical and epidemiological significance of serum PreS1/anti-PreS1 in HBV infection.
Mi Z; Feng F; Zhang X; Lian Z; Wang H; Tong Y
Chin Med J (Engl); 1999 Apr; 112(4):321-4. PubMed ID: 11593530
[TBL] [Abstract][Full Text] [Related]
9. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study.
Duong TN; Horiike N; Michitaka K; Yan C; Mizokami M; Tanaka Y; Jyoko K; Yamamoto K; Miyaoka H; Yamashita Y; Ohno N; Onji M
J Med Virol; 2004 Apr; 72(4):551-7. PubMed ID: 14981757
[TBL] [Abstract][Full Text] [Related]
10. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
Evans AA; O'Connell AP; Pugh JC; Mason WS; Shen FM; Chen GC; Lin WY; Dia A; M'Boup S; Dramé B; London WT
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):559-65. PubMed ID: 9681522
[TBL] [Abstract][Full Text] [Related]
11. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes.
Petit MA; Capel F; Dubanchet S; Mabit H
Virology; 1992 Mar; 187(1):211-22. PubMed ID: 1736525
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
Murakami Y; Minami M; Daimon Y; Okanoue T
J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
[TBL] [Abstract][Full Text] [Related]
13. Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.
Rodríguez-Iñigo E; Mariscal L; Bartolomé J; Castillo I; Navacerrada C; Ortiz-Movilla N; Pardo M; Carreño V
J Med Virol; 2003 Aug; 70(4):571-80. PubMed ID: 12794719
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
[TBL] [Abstract][Full Text] [Related]
16. Adsorption and penetration of hepatitis B virus in a nonpermissive cell line.
Qiao M; Macnaughton TB; Gowans EJ
Virology; 1994 Jun; 201(2):356-63. PubMed ID: 8184545
[TBL] [Abstract][Full Text] [Related]
17. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.
Niitsuma H; Ishii M; Miura M; Kobayashi K; Toyota T
Am J Gastroenterol; 1997 Jan; 92(1):119-23. PubMed ID: 8995950
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the histological and serological parameters of patients with hepatitis delta virus in active and inactive hepatitis B virus carriers.
Shaikh S; Ram DB; Tanveer S; Talpur A
J Coll Physicians Surg Pak; 2014 Feb; 24(2):97-100. PubMed ID: 24491002
[TBL] [Abstract][Full Text] [Related]
19. Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry.
Owada T; Matsubayashi K; Sakata H; Ihara H; Sato S; Ikebuchi K; Kato T; Azuma H; Ikeda H
J Viral Hepat; 2006 Jan; 13(1):11-8. PubMed ID: 16364077
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the outcome and severity of hepadnaviral hepatitis in woodchucks by antibodies to hepatic asialoglycoprotein receptor.
Diao J; Slaney DM; Michalak TI
Hepatology; 2003 Sep; 38(3):629-38. PubMed ID: 12939589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
